FDA USA - Search News

FDA bans Red 3 food dye

CNN on MSN · 3d

FDA bans red dye No. 3 from food, drinks and ingested drugs in the US

Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic Act. The clause, in part, “prohibits the FDA from approving a color additive that is ingested if it causes cancer in animals or humans when ingested,” according to the agency .

The National Law Review · 21h

FDA Revokes Authorization for the Use of Red Dye No. 3 in Food and Ingestible Drugs

On 15 January 2025, the US Food and Drug Administration (FDA) announced that it will revoke the color additive authorization for use of FD&C Red No. 3 in food (including dietary supplements) and ingestible drugs.

MarketWatch on MSN · 12h

It starts with Red No. 3. These are the dyes and food additives that could be banned next.

With the recent news that the Food and Drug Administration is banning Red No. 3, the artificial dye that is considered a potential carcinogen, some experts are saying it could be the start of a much larger trend to remove any number of additives from some of our favorite foods and drinks.

FDA 'Closely Monitoring' ZYN Nicotine Pouches

BBC on MSN · 1d

US FDA officially authorises Zyn nicotine pouches for sale

The pouches are used by less than 2% of US teens, the FDA said in granting the application allowing them to continue to be sold.

U.S. News & World Report · 1d

FDA Approves Marketing of Nicotine Pouches

Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products. Nicotine pouches -- small synthetic fiber pouches containing nicotine -- are designed to be placed between a person's gum and lip.

USA TODAY on MSN · 1d

FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes

The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine pouches.

20hon MSN

US FDA approves AstraZeneca's drug for breast cancer

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

FDA issues warning against using epinephrine nasal solutions from BPI Labs, Endo USA

The FDA has advised health care professionals that they should not use unapproved epinephrine nasal solutions manufactured by ...

1don MSN

FDA's Suggested Change to Food Packaging Raises Concerns Among Experts

Newsweek spoke to experts about the FDA's suggestion to place nutrition information on the front of packaged foods.

1d

US FDA approves Amgen's colorectal cancer therapy

The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients ...

1d

Medicare drug price negotiations to target Ozempic, Wegovy and other drugs

The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of ...

Monthly Prescribing Reference1d

FDA Warns Clinicians Not to Confuse Epinephrine Products Due to Similar Packaging

Since 2016, the FDA has received 25 reports of unapproved epinephrine nasal solution being confused with approved epinephrine injection.

4d

US judge blocks FDA graphic warning label requirement for cigarettes

A federal judge in Texas has blocked the U.S. Food and Drug Administration from enforcing a looming requirement that ...

1h

Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year

Like many industries preparing for Donald Trump's second term as president, the prospects for the healthcare industry are a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results